The clinical community oncology program led by Ascension Via Christi has joined the Alliance for Clinical Trials in Oncology — part of the National Cancer Institute’s National Clinical Trials Network, or NCTN. It also has a new name: Cancer Research of Kansas.
Most patients diagnosed with cancer aren’t eager to spend months getting treatment or recovering from surgery. But patients referred for treatment at Ascension Via Christi CyberKnife Center in Wichita don’t have to, because CyberKnife can hone in on lethal cancerous or unhealthy tissue with pinpoint precision in just one to five treatments and requires no incisions or sedation.
Hyperbaric therapy can be a treatment option for the small percentage of male patients who develop hemorrhagic cystitis or proctitis following appropriate radiation therapy for prostate cancer.
For Marcie Harris Charles, 60, and her daughter, Megan Charles Kramer, 37, both from western Kansas, receiving treatment close to home for their very different breast cancers has made a huge impact on their families, as well as themselves.
About 200 Wichita women and Wichita oncologist Pavan Reddy, MD, were part of a long-term study that changes the standard of care in treating women with early stage breast cancer by sparing them from chemotherapy treatment.
The results of the international clinical trial, called TAILORx,...
Via Christi Hospital St. Francis in Wichita launched its Cancer Outreach and Risk Assessment (CORA) program in July 2015 to provide cancer risk assessment and genetic counseling — becoming the second such program in Kansas.
When radiation oncologist Claudia Perez-Tamayo, MD, FACR, FACRO, came to Kansas in 1989, she saw an opportunity to bring the latest in cancer treatment — such as her work in intensity-modulated radiation therapy — to underserved areas.
The Sisters of the Sorrowful Mother were ahead of their time when they recruited Irish oncologist Harry Hynes, MD, who had just completed his fellowship training at the Mayo Clinic, to Wichita. At the time, cancer care was a much-needed but uncommon level of specialty care outside of major...
CyberKnife still ‘the gold standard’ for stereotactic body radiosurgery treatment
Christopher Halphen, DO, completed his fellowship in orthopedic musculoskeletal oncology and complex limb reconstruction at Emory University Medical Center in Atlanta last year, making him one of fewer than 200 actively practicing fellowship-trained orthopedic oncologists nationwide.
- 1 of 3
- next ›